Insider Transactions in Q2 2021 at Boston Scientific Corp (BSX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
SELL
Open market or private sale
|
Direct |
16,450
-47.99%
|
$723,800
$44.03 P/Share
|
|
Jun 24
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
BUY
Exercise of conversion of derivative security
|
Direct |
16,450
+32.43%
|
$279,650
$17.26 P/Share
|
|
Jun 16
2021
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Open market or private sale
|
Direct |
8,833
-23.83%
|
$370,986
$42.76 P/Share
|
|
Jun 15
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
3,322
-1.87%
|
$139,524
$42.7 P/Share
|
|
Jun 15
2021
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Open market or private sale
|
Direct |
7,901
-17.57%
|
$331,842
$42.78 P/Share
|
|
Jun 15
2021
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,901
+14.95%
|
$94,812
$12.89 P/Share
|
|
Jun 14
2021
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Open market or private sale
|
Direct |
5,000
-11.89%
|
$210,000
$42.94 P/Share
|
|
Jun 14
2021
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+10.62%
|
$65,000
$13.08 P/Share
|
|
Jun 03
2021
|
David A Pierce EVP Pres MedSurg |
SELL
Open market or private sale
|
Direct |
1,654
-44.57%
|
$67,814
$41.36 P/Share
|
|
Jun 01
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
696
-2.23%
|
$29,232
$42.93 P/Share
|
|
Jun 01
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,762
+5.35%
|
-
|
|
Jun 01
2021
|
Edward F Mackey EVP, Operations |
SELL
Open market or private sale
|
Direct |
68,173
-74.19%
|
$2,863,266
$42.71 P/Share
|
|
Jun 01
2021
|
David A Pierce EVP Pres MedSurg |
SELL
Payment of exercise price or tax liability
|
Direct |
1,319
-26.22%
|
$55,398
$42.93 P/Share
|
|
Jun 01
2021
|
David A Pierce EVP Pres MedSurg |
BUY
Exercise of conversion of derivative security
|
Direct |
2,973
+37.15%
|
-
|
|
May 28
2021
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
SELL
Open market or private sale
|
Direct |
78,192
-31.91%
|
$3,284,064
$42.59 P/Share
|
|
May 14
2021
|
Michael F Mahoney Chairman, President & CEO |
SELL
Bona fide gift
|
Direct |
34,965
-1.65%
|
-
|
|
May 06
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Bona fide gift
|
Direct |
12,000
-4.79%
|
-
|
|
May 06
2021
|
Nelda J Connors Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,098
+16.03%
|
-
|
|
May 06
2021
|
Charles J Dockendorff Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,202
+8.6%
|
-
|
|
May 06
2021
|
John E Sununu Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,763
+10.43%
|
-
|
|
May 06
2021
|
David J Roux Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,763
+6.85%
|
-
|
|
May 06
2021
|
Ellen M Zane Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,763
+11.46%
|
-
|
|
May 01
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
SELL
Payment of exercise price or tax liability
|
Direct |
605
-3.28%
|
$26,015
$43.6 P/Share
|
|
May 01
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
BUY
Exercise of conversion of derivative security
|
Direct |
2,061
+10.06%
|
-
|
|
Apr 30
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Bona fide gift
|
Direct |
2,358
-1.31%
|
-
|
|
Apr 30
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
13,750
-7.09%
|
$591,250
$43.72 P/Share
|
|
Apr 30
2021
|
John Bradley Sorenson EVP, Global Operations |
SELL
Bona fide gift
|
Direct |
1,786
-3.81%
|
-
|
|
Apr 30
2021
|
John Bradley Sorenson EVP, Global Operations |
SELL
Open market or private sale
|
Direct |
3,572
-7.07%
|
$153,596
$43.51 P/Share
|
|
Apr 28
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
48,439
-25.82%
|
$2,082,877
$43.98 P/Share
|
|
Apr 28
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
48,439
+20.52%
|
$339,073
$7.39 P/Share
|
|
Apr 15
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
28,123
-16.81%
|
$1,124,920
$40.95 P/Share
|
|
Apr 15
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
28,123
+14.39%
|
$168,738
$6.28 P/Share
|
|
Apr 15
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct |
9,676
-24.76%
|
$387,040
$40.0 P/Share
|
|
Apr 15
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
4,250
+9.81%
|
$55,250
$13.08 P/Share
|
|
Apr 01
2021
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Open market or private sale
|
Direct |
700
-5.17%
|
$26,600
$38.61 P/Share
|